mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.01 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.02 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
Z-LLNle-CHO |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.02 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.1 |
0.02 |